DOSTARLIMAB vs DOXERCALCIFEROL: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
DOSTARLIMAB vs DOXERCALCIFEROL: Safety Overview
| Metric | DOSTARLIMAB | DOXERCALCIFEROL |
|---|---|---|
| Total FAERS Reports | 893 | 137 |
| Deaths Reported | 130 | 7 |
| Death Rate | 14.6% | 5.1% |
| Hospitalizations | 441 | 34 |
| Average Patient Age | 65.8 yrs | 54.9 yrs |
| % Female Patients | 91.6% | 50.0% |
| FDA Approval Date | N/A | Apr 23, 2004 |
| Manufacturer | GlaxoSmithKline LLC | Alembic Pharmaceuticals Inc. |
| Route | INTRAVENOUS | INTRAVENOUS |
| Marketing Status | N/A | Discontinued |